NewsNorthern Leaf Raises £14m to Progress Jersey Medical Cannabis...

Northern Leaf Raises £14m to Progress Jersey Medical Cannabis Facility And LSE Listing

-

CHANNEL Islands medical cannabis cultivator Northern Leaf has raised £14m in a five-times over-subscribed, pre-IPO fund-raising round. 

Northern Leaf will use the money to progress the the development of its 75,000 sq ft Jersey growing facility – equivalent to the size of a football pitch – and associated extraction and production facilities.

Northern Leaf advisor Tristan Gervais, Chrystal Capital’s Head of Cannabis, said it had secured support from five global institutional investors.

The capital raise comes just months after Jersey-based Northern Leaf became the only second firm to receive a commercial licence to grow medical cannabis in the British Isles.

First Crop Planted

Northern Leaf anticipates listing on the London Stock Exchange later this year and in doing so will join a growing number of cannabis companies.

Speaking to BusinessCann recently Mr Gervais said it was ‘seeing strong client demand to invest in quality, private medical cannabis companies, such as Northern Leaf’.

Northern leaf’s cannabis plants will be processed and cannabinoids extracted at the Jersey facility which will also produce pharmaceutical-grade flowers and oils for the wholesale market, or to be processed into Northern’s own brands. It is also exploring ways to enter the UK market through the ‘specials’ medicine’ route.

Northern Leaf’s Jersey facilities are set to achieve achieve both EU GMP (Good Manufacturing Practice) and GACP (Good Agricultural and Collection Practice) qualifications.

It aims to partner with UK and European cannabis distributors and processors in order to supply high-grade products for scientific and medicinal purposes across the Continent.

Northern Leaf became only the second company to secure a commercial high-THC medical cannabis licence in over 20 years after GW Pharmaceuticals in 1998.

Planting is due to get underway of the first crop of THC cannabis plants at Northern Leaf’s Jersey facility later this year. 

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover...

Columbia Care Platinum Joins Forces With Poppy Jamie

Leading organic, vegan and regeneratively-farmed, plant-based CBD brand, Columbia Care Platinum(www.shop.col-care.uk), announces it has teamed up with Poppy Jamie, mental wellbeing...

InterCure Announces European Expansion with International Cannabis Brand Cookies

InterCure Ltd. today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies. The parties entered...

Groups From 56 Countries Ask UN To Ensure Secretive ‘Cannabis Initiative’ Is Open To Public Scrutiny

ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy...

The New Common Agricultural Policy Has Been Adopted And the Maximum THC Level on the Field Has Been Restored to 0.3%

It was in October 2020 when we announced that the European Parliament had voted in favour of restoring the...

European Medical Cannabis Tech Accelerator Opens Call for Submissions

The first and only hybrid tech accelerator in Europe dedicated to the medical cannabis industry offers €100,000 grant to early-stage startups from around the world.

Must read

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior...

You might also likeRELATED
Recommended to you